These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 785454

  • 1. Chronic peritoneal dialysis in diabetic patients with end-stage renal failure.
    Finkelstein FO, Kliger AS, Bastl C, Yap P, Goffinet J.
    Proc Clin Dial Transplant Forum; 1975 Nov; 5():142-5. PubMed ID: 785454
    [No Abstract] [Full Text] [Related]

  • 2. [Clearance of urea, creatinine, beta 2 microglobulin and the loss of proteins in treatment with continuous ambulatory peritoneal dialysis].
    Kozjak D, Prejac M, Jeren-Struić B, Gudelj J, Kovarbasić B.
    Lijec Vjesn; 1982 Nov; 104(11-12):532-5. PubMed ID: 6764943
    [No Abstract] [Full Text] [Related]

  • 3. Peritoneal urea and creatinine clearance in non insulin dependent diabetes mellitus.
    López PC, Frati-Munari AC, Ariza-Andraca CR.
    Arch Invest Med (Mex); 1986 Nov; 17(2):177-85. PubMed ID: 3592891
    [No Abstract] [Full Text] [Related]

  • 4. Estimation of residual glomerular filtration rate and renal Kt/Vurea from creatinine clearance in end-stage renal disease patients. The Netherlands Cooperative Study on the Adequacy of Dialysis.
    Korevaar JC, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT.
    Adv Perit Dial; 1999 Nov; 15():132-7. PubMed ID: 10682088
    [Abstract] [Full Text] [Related]

  • 5. Disorders of protein and lipid metabolism associated with chronic renal failure and chronic dialysis.
    Krumlovsky FA.
    Ann Clin Lab Sci; 1981 Nov; 11(4):350-60. PubMed ID: 7023349
    [Abstract] [Full Text] [Related]

  • 6. Growth hormone therapy and lipid profile in children on chronic peritoneal dialysis.
    Jedrzejowski A, Pańczyk-Tomaszewska M, Roszkowska-Blaim M, Lis D, Gałazka B, Dyras P.
    Pediatr Nephrol; 2002 Oct; 17(10):830-6. PubMed ID: 12376812
    [Abstract] [Full Text] [Related]

  • 7. Treatment of end-stage renal failure due to diabetes mellitus with peritoneal dialysis--treatment of choice?
    Plaksin J, Boner G, Rosenfeld JB.
    Med Interne; 1982 Oct; 20(4):283-8. PubMed ID: 6985496
    [Abstract] [Full Text] [Related]

  • 8. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
    Bajo MA, del Peso G, Jiménez V, Aguilera A, Villar A, Jiménez C, Selgas R.
    Adv Perit Dial; 2000 Oct; 16():170-3. PubMed ID: 11045286
    [Abstract] [Full Text] [Related]

  • 9. Long-term survival with peritoneal dialysis in ESRD due to diabetes.
    Passadakis P, Thodis E, Vargemezis V, Oreopoulos D.
    Clin Nephrol; 2001 Oct; 56(4):257-70. PubMed ID: 11680655
    [Abstract] [Full Text] [Related]

  • 10. Increased peritoneal solute transport in diabetic peritoneal dialysis patients.
    Lin JJ, Wadhwa NK, Suh H, Cabralda T, Patlak CS.
    Adv Perit Dial; 1995 Oct; 11():63-6. PubMed ID: 8534740
    [Abstract] [Full Text] [Related]

  • 11. [Terminal renal insufficiency and diabetes].
    Coronel Díaz F, Naranjo Gómez P, Alvarez Otero MJ, Prats Sánchez D.
    Rev Clin Esp; 1983 May 31; 169(4):221-8. PubMed ID: 6353495
    [No Abstract] [Full Text] [Related]

  • 12. [Intermittent peritoneal chronic dialysis in diabetic patients: effect of the technique on blood glucose and protein loss during the procedure].
    García Ortiz R, Gómez M, Olea C.
    Rev Med Chil; 1989 Dec 31; 117(12):1367-73. PubMed ID: 2519375
    [Abstract] [Full Text] [Related]

  • 13. [Role of peritoneal dialysis in the treatment of terminal chronic renal insufficiency. Survival of patients and method].
    Ryckelynck JP, Hurault de Ligny B, Levaltier B, Cardineau E, Le Goff C, Batho JM.
    Nephrologie; 1995 Dec 31; 16(1):85-92. PubMed ID: 7700425
    [Abstract] [Full Text] [Related]

  • 14. [Indoprofen in chronic intermittent peritoneal dialysis: effects in the clearance of small molecules and protein loss].
    García-Ortiz R, Campos G, Silva G, Gómez M, Uribe C, Herrera O.
    Rev Med Chil; 1989 May 31; 117(5):528-33. PubMed ID: 2519164
    [Abstract] [Full Text] [Related]

  • 15. Differences in fluid and solute transport between diabetic and nondiabetic patients at the onset of CAPD.
    Serlie MJ, Struijk DG, de Blok K, Krediet RT.
    Adv Perit Dial; 1997 May 31; 13():29-32. PubMed ID: 9360646
    [Abstract] [Full Text] [Related]

  • 16. Nutritional care of patients with renal failure and diabetes.
    Levine SE.
    J Am Diet Assoc; 1982 Sep 31; 81(3):261-7. PubMed ID: 7050217
    [Abstract] [Full Text] [Related]

  • 17. [Peritoneal equilibration test].
    Morduchowicz G, Feldman T, van Dyk DJ, Boner G.
    Harefuah; 1990 Mar 15; 118(6):312-5. PubMed ID: 2347531
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Adequacy of solute and water removal in children treated with nightly intermittent peritoneal dialysis.
    Edefonti A, Picca M, Ghio L, Bassi S, Cattarelli D, Leccese V.
    Adv Perit Dial; 1992 Mar 15; 8():402-5. PubMed ID: 1361833
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of lactate and acetate on clinical peritoneal clearances.
    Rubin J, Nolph KD, Arfaania D, Wiegman DL, Miller FN, Harris PD.
    Clin Nephrol; 1979 Oct 15; 12(4):145-7. PubMed ID: 509789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.